Assuming the 40.5 and 41c buyers are not forced into being sellers, then available stock is bound to dry up soon.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025